Neurology Journal Broadens Recruitment Efforts for Clinical Research Trials

[Guest guest]

Neurology Journal Broadens Recruitment Efforts for Clinical Research

Trials

ST. PAUL, Minn. – Clinical research trials are a key part of the process

of developing new treatment therapies for numerous neurological

disorders. Clinical trials need not

just patients but patients that meet the strict eligibility requirements

in well-designed controlled trials. With the July 13 issue, Neurology is

introducing a new clinical trials recruiting section organized by

disease.

In the same issue, Neurology “Patient Page” editor Robin Brey, MD, a

neurologist at the University of Texas in San , describes therapy

advancements in stroke, epilepsy, Parkinson’s disease, multiple

sclerosis and migraine that were dependent on clinical research trials.

According to the Association of Clinical Research Professionals

(www.acrpnet.org), close to 80 percent of clinical trials have problems

in recruitment that delay or even

prevent their completion.

Information about clinical research studies for neurological diseases is

available on the Neurology Website at www.neurology.org, and on the

National Institute of Neurological Diseases and Stroke

Website at www.nih.ninds.gov.